- Home
- BCSF vs INMD Comparison
BCSF vs INMD Comparison
Compare BCSF & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCSF
- INMD
- Stock Information
- Founded
- BCSF 2015
- INMD 2008
- Country
- BCSF United States
- INMD Israel
- Employees
- BCSF N/A
- INMD N/A
- Industry
- BCSF Finance/Investors Services
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BCSF Finance
- INMD Health Care
- Exchange
- BCSF Nasdaq
- INMD Nasdaq
- Market Cap
- BCSF 901.0M
- INMD 964.9M
- IPO Year
- BCSF 2018
- INMD 2019
- Fundamental
- Price
- BCSF $14.07
- INMD $14.93
- Analyst Decision
- BCSF Buy
- INMD Hold
- Analyst Count
- BCSF 2
- INMD 6
- Target Price
- BCSF $16.50
- INMD $17.06
- AVG Volume (30 Days)
- BCSF 393.1K
- INMD 812.7K
- Earning Date
- BCSF 11-10-2025
- INMD 11-05-2025
- Dividend Yield
- BCSF 12.71%
- INMD N/A
- EPS Growth
- BCSF N/A
- INMD 46.63
- EPS
- BCSF 1.66
- INMD 2.54
- Revenue
- BCSF $283,687,000.00
- INMD $401,561,000.00
- Revenue This Year
- BCSF N/A
- INMD N/A
- Revenue Next Year
- BCSF N/A
- INMD $5.14
- P/E Ratio
- BCSF $8.52
- INMD $5.89
- Revenue Growth
- BCSF N/A
- INMD N/A
- 52 Week Low
- BCSF $13.20
- INMD $13.14
- 52 Week High
- BCSF $19.21
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- BCSF 46.99
- INMD 45.05
- Support Level
- BCSF $14.01
- INMD $15.03
- Resistance Level
- BCSF $14.55
- INMD $15.86
- Average True Range (ATR)
- BCSF 0.28
- INMD 0.43
- MACD
- BCSF 0.08
- INMD -0.09
- Stochastic Oscillator
- BCSF 62.20
- INMD 5.04
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.